• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    16.14 Down 0.66(3.93%) Feb 5, 4:00PM EST
    |After Hours : 16.14 Down 0.00 (0.02%) Feb 5, 5:25PM EST
    Prev Close:16.80
    Open:16.74
    Bid:15.88 x 200
    Ask:19.00 x 1000
    1y Target Est:27.13
    Beta:1.67348
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:16.10 - 16.82
    52wk Range:13.27 - 33.74
    Volume:2,226,728
    Avg Vol (3m):1,843,590
    Market Cap:976.17M
    P/E (ttm):19.73
    EPS (ttm):0.82
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPODown 3.93%976.17M
    PFEUp 0.10%179.22B
    MRKUp 1.63%137.95B

    Key Statistics

    Forward P/E (1 yr):9.44
    P/S (ttm):2.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.79
    Quarterly EPS Est (Dec-15) :0.29
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.68

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback